A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia.
Robins HI, Katschinski DM, Longo W, Grosen E, Wilding G, Gillis W, Kraemer C, Tiggelaar CL, Rushing D, Stewart JA, Spriggs D, Love R, Arzoomanian RZ, Feierabend C, Alberti D, Morgan K, Simon K, d'Oleire F.
Robins HI, et al. Among authors: simon k.
Cancer Chemother Pharmacol. 1999;43(5):409-14. doi: 10.1007/s002800050915.
Cancer Chemother Pharmacol. 1999.
PMID: 10100597